PMID- 34287043 OWN - NLM STAT- MEDLINE DCOM- 20210922 LR - 20220310 IS - 1098-5514 (Electronic) IS - 0022-538X (Print) IS - 0022-538X (Linking) VI - 95 IP - 19 DP - 2021 Sep 9 TI - EGR1 Suppresses Porcine Epidemic Diarrhea Virus Replication by Regulating IRAV To Degrade Viral Nucleocapsid Protein. PG - e0064521 LID - 10.1128/JVI.00645-21 [doi] LID - e00645-21 AB - Porcine epidemic diarrhea virus (PEDV) is a globally distributed alphacoronavirus that has reemerged lately, resulting in large economic losses. During viral infection, type I interferon (IFN-I) plays a vital role in the antiviral innate immunity. However, PEDV has evolved strategies to limit IFN-I production. To suppress virus replication, the host must activate IFN-stimulated genes and some host restriction factors to circumvent viral replication. This study observed that PEDV infection induced early growth response gene 1 (EGR1) expression in PEDV-permissive cells. EGR1 overexpression remarkably suppressed PEDV replication. In contrast, depletion of EGR1 led to a significant increase in viral replication. EGR1 suppressed PEDV replication by directly binding to the IFN-regulated antiviral (IRAV) promoter and upregulating IRAV expression. A detailed analysis revealed that IRAV interacts and colocalizes with the PEDV nucleocapsid (N) protein, inducing N protein degradation via the E3 ubiquitin ligase MARCH8 to catalyze N protein ubiquitination. Knockdown of endogenous MARCH8 significantly reversed IRAV-mediated N protein degradation. The collective findings demonstrate a new mechanism of EGR1-mediated viral restriction, in which EGR1 upregulates the expression of IRAV to degrade PEDV N protein through MARCH8. IMPORTANCE PEDV is a highly contagious enteric coronavirus that has rapidly emerged worldwide and has caused severe economic losses. No currently available drugs or vaccines can effectively control PEDV. PEDV has evolved many strategies to limit IFN-I production. We identified EGR1 as a novel host restriction factor and demonstrated that EGR1 suppresses PEDV replication by directly binding to the IRAV promoter and upregulating the expression of IRAV, which interacts with and degrades the PEDV N protein via the E3 ubiquitin ligase MARCH8 to catalyze nucleocapsid protein ubiquitination, which adds another layer of complexity to the innate antiviral immunity of this newly identified restriction factor. A better understanding of the innate immune response to PEDV infection will aid the development of novel therapeutic targets and more effective vaccines against virus infection. FAU - Wang, Hua AU - Wang H AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. FAU - Kong, Ning AU - Kong N AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. AD - Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, People's Republic of China. FAU - Jiao, Yajuan AU - Jiao Y AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. FAU - Dong, Sujie AU - Dong S AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. FAU - Sun, Dage AU - Sun D AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. FAU - Chen, Xiaoyong AU - Chen X AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. FAU - Zheng, Hao AU - Zheng H AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. AD - Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, People's Republic of China. FAU - Tong, Wu AU - Tong W AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. AD - Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, People's Republic of China. FAU - Yu, Hai AU - Yu H AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. AD - Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, People's Republic of China. FAU - Yu, Lingxue AU - Yu L AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. AD - Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, People's Republic of China. FAU - Zhang, Wen AU - Zhang W AD - School of Medicine, Jiangsu University, Zhenjiang, People's Republic of China. FAU - Tong, Guangzhi AU - Tong G AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. AD - Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, People's Republic of China. FAU - Shan, Tongling AU - Shan T AUID- ORCID: 0000-0002-5329-6349 AD - Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China. AD - Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, People's Republic of China. LA - eng GR - 2016YFD0500103/National Key Research and Development Programs of China/ GR - 19ZR1469100/Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation)/ GR - 31872478/National Natural Science Foundation of China (NSFC)/ PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210909 PL - United States TA - J Virol JT - Journal of virology JID - 0113724 RN - 0 (Antiviral Agents) RN - 0 (EGR1 protein, human) RN - 0 (Early Growth Response Protein 1) RN - 0 (Interferon Type I) RN - 0 (Nucleocapsid Proteins) RN - 0 (RNA-Binding Proteins) RN - 0 (SHFL protein, human) RN - EC 2.3.2.27 (MARCHF8 protein, human) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) SB - IM MH - Animals MH - Antiviral Agents/metabolism MH - Chlorocebus aethiops MH - Coronavirus Infections MH - Early Growth Response Protein 1/*metabolism/*pharmacology MH - HEK293 Cells MH - Host-Pathogen Interactions MH - Humans MH - Immunity, Innate MH - Interferon Type I/metabolism MH - Nucleocapsid/metabolism MH - Nucleocapsid Proteins/*metabolism MH - Porcine epidemic diarrhea virus/*drug effects/genetics MH - RNA-Binding Proteins/*metabolism MH - Swine MH - Swine Diseases/virology MH - Ubiquitin-Protein Ligases/genetics/metabolism MH - Vero Cells MH - Virus Replication/*drug effects PMC - PMC8428380 OTO - NOTNLM OT - EGR1 OT - IRAV OT - PEDV OT - antiviral response OT - nucleocapsid protein OT - viral replication EDAT- 2021/07/22 06:00 MHDA- 2021/09/23 06:00 PMCR- 2022/03/09 CRDT- 2021/07/21 12:34 PHST- 2021/07/22 06:00 [pubmed] PHST- 2021/09/23 06:00 [medline] PHST- 2021/07/21 12:34 [entrez] PHST- 2022/03/09 00:00 [pmc-release] AID - 00645-21 [pii] AID - 10.1128/JVI.00645-21 [doi] PST - ppublish SO - J Virol. 2021 Sep 9;95(19):e0064521. doi: 10.1128/JVI.00645-21. Epub 2021 Sep 9.